AASLD: High SVR Rates Seen with Telaprevir for Hepatitis C (CME/...

Courtesy MedPage Today Infectious Disease  Fri, 11/06/2009 - 15:10

BOSTON (MedPage Today) -- Availability of direct antiviral drugs for hepatitis C virus (HCV) infection moved another step closer to realization, with favorable results reported here for telaprevir in two Phase II studies.


 

More related items

ASN: HCV Infection Virtually Untreated in Dialysis...
PHILADELPHIA (MedPage Today) -- Hepatitis C virus (HCV) infection is associated with an increase in mortality in patients on hemodialysis, but treatment is rare in that population,...

Drug Ups Response Rate in Refractory Hepatitis C...
(MedPage Today) -- The protease inhibitor, telaprevir (Incivek), markedly improved response rates in patients with hard-to-treat hepatitis C virus (HCV) infection, compared with standard...

DDW: Study Backs HCV Screens for All Boomers (CME/CE)
CHICAGO (MedPage Today) -- Screening all baby boomers for hepatitis C virus (HCV) infection could save tens of thousands of lives at a very acceptable cost, a researcher said here.

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com